BRIEF-Adocia and Lilly initiate a new phase 1b study of BioChaperone Lispro

* Adocia and Eli Lilly and Company initiate a new phase 1b study of repeat administration of ultra-rapid BioChaperone Lispro in patients with type 2 diabetes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.